Building AI tools to streamline funding processes for founders, specifically underrepresented founders. 

   Stage at Investment: Pre-seed

   Founders: Argentina Beltran

Why we invested:

InclusifAI, founded and led by a woman with deep roots in finance and startup incubation, tackles one of the most persistent bottlenecks in early-stage capital: founders and investors from diverse backgrounds simply not finding eachother. 

Diversity isn't a feature bolted onto InclusifAI but rather the reason the platform exists. The result is a platform positioned to do for capital access what few others have managed: turn a well-known pain point into a scalable solution. 

AI powered blood test for microRNA multi-disease screening.

   Stage at Investment: Seed

   Founders: Victoria Xu,  Hai Hu, Chistopher M. Gallagher 

Why we invested:

miRoncol Health, led by a highly driven female CEO, has taken Nobel Prize-winning science and turned it into an early pre-screening tool that is inexpensive enough and simple enough to reach anyone, anywhere, including remote and underserved communities that have historically been locked out of early detection. 

The impact case is as clear as it gets: earlier cancer diagnosis means dramatically better long-term outcomes. 

PakVille designs and manufactures modular buildings, made from 100% recycled materials. 

   Stage at Investment: Seed

   Founders: Parinaz Pakniat

Why we invested:

PakVille is a female founded company that has engineered a way to build homes with plastics that doesn't come with the microplastics problem. The result is a construction material that cuts costs to builders by 35% compared to regular home construction, without the enviornmental trade-off that's kept plastic-based building out of serious construction. 

PakVille combines genuine innovation with real costs savings to translate a compelling pitch into real commercial traction. 

Axon Health creates an all-inclusive platform for client care. 

   Stage at Investment: Seed

   Founders: Konain Qurban

Why we invested:

Axon health sits between healthcare delivery and meaningful socialimpact. After working in addiction recovery, the founder saw firsthand how fragmented systems forced frontline workers to spend too much time on administrative tasks while patients too often slipped through the cracks. 

By centralizing care management into a single platform that follows patients across treatmnet settings, improving continuity of care and freeing providers to focus on what matters most: delivering timely, high-quality support to the people who need it.

Arma Biosciences is building a new sensor technology for biomarker-informed digital healthcare.

   Stage at Investment: Seed

   ​Founders: Shana Kelley, Surath Gomis, and Hanie Yousefi

Why we invested:

Arma Biosciences is redefining how diseases are detected by making diagnostics more accessible, affordable and scalable. Rather than relying on traditional blood tests, Arma's biomarket sensor technology can detect a wide range of diseases using everyday bodily fluids, opening the door to earlier diagnosis and disease prevention for more people. 

The company combines a world-renowned founder with deep scientific expertise and a CEO with proven track record of bringing startups to market, creating a strong foundation for execution

Sonaro uses AI and 3-dimensional analyses to diagnose cardiovascular risk from traditional ultrasound exams. 

   Stage at Investment: Pre-seed

   Founders: Dr. Karina Gasbarrino, Dr. Kashif Khan

Why we invested:

Sonaro AI is a Canadian, female-founded medtech company that has engineered a way to transform standard 2D carotid ultrasound into fully automated 3D vascular models, delivering quantitative stroke-risk report in under 10 minutes. 

This removes the need for specialized 3D imaging infrastructure and making reliable, standardized stroke-risk screening accessible at the point of care. This results in earlier stroke detection for more patients at a lower cost. 

ByroSphere is transforming moss into living factories to produce sustainable, high-performance skincare ingredients.

   Stage at Investment: Pre-seed

   Founders: Dr. Liz Mahon, Dr. Hila Behar

Why we invested:

Bryosphere is a Canadian, female founded, biotechnology company that has engineered a way to turn moss into sustainable bio-factories for producing rare, high-value skincare ingredients.

This has resulted in a plant-based innovation commercially accessible, delivering sustainable, cost-efficient ingredients at scale without the trade-offs that have kept this kind of innovation out of serious use.